Background Background There is accumulating
There is accumulating evidence of hypothalamic^pituitaryêvidence of hypothalamic^pituitaryâ drenal (HPA) axis disturbances in chronic adrenal (HPA) axis disturbances in chronic fatigue syndrome (CFS).The salivary fatigue syndrome (CFS).The salivary cortisol response to awakening has been cortisol response to awakening has been described recently as a non-invasive test of described recently as a non-invasive test of the capacity of the HPA axis to respond to the capacity of the HPA axis to respond to stress.The results of this test correlate stress.The results of this test correlate closely with those of more invasive closely with those of more invasive dynamic tests reported in the literature; dynamic tests reported in the literature; furthermore, it can be undertaken in a furthermore, it can be undertaken in a naturalistic setting. naturalistic setting.
Aims
Aims To assess the HPA axis using the To assess the HPA axis using the salivary cortisol response to awakening in salivary cortisol response to awakening in CFS. CFS.
Method Method We measured salivary cortisol
We measured salivary cortisol upon awakening and10, 20, 30 and 60 min upon awakening and10, 20, 30 and 60 min afterwards in 56 patients with CFS and 35 afterwards in 56 patients with CFS and 35 healthy volunteers. healthy volunteers.
Results

Results Patients had a lower cortisol
Patients had a lower cortisol response to awakening, measured by the response to awakening, measured by the area under the curve. area under the curve.
Conclusions Conclusions This naturalistic test ofthe
This naturalistic testofthe HPA axis response to stress showed HPA axis response to stress showed impaired HPA axis function in CFS. impaired HPA axis function in CFS.
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Chronic fatigue syndrome (CFS) is a Chronic fatigue syndrome (CFS) is a disabling disorder characterised by extreme disabling disorder characterised by extreme fatigue and other related symptoms fatigue and other related symptoms (Fukuda (Fukuda et al et al, 1994) , and is most probably , 1994), and is most probably of multi-factorial aetiology (Wessely of multi-factorial aetiology (Wessely et al et al, , 1998) . Of the putative biological com-1998). Of the putative biological components, dysfunction of the hypothalamicponents, dysfunction of the hypothalamicpituitary-adrenal (HPA) axis has been pituitary-adrenal (HPA) axis has been implicated because of the links between implicated because of the links between physical or psychological stress and illness physical or psychological stress and illness onset, the comorbidity with major depresonset, the comorbidity with major depression (found in around a half of most sion (found in around a half of most samples) and the predominance of fatigue samples) and the predominance of fatigue in disorders of the HPA axis, such as in disorders of the HPA axis, such as Addison's disease (Cleare, 2001) . Evidence Addison's disease (Cleare, 2001 ). Evidence to date supports mild hypocortisolism in to date supports mild hypocortisolism in some subjects, but with variability between some subjects, but with variability between studies depending on the method used to studies depending on the method used to measure cortisol levels and the likely measure cortisol levels and the likely heterogeneity of patient samples (Cleare, heterogeneity of patient samples (Cleare, 2003) . Because of difficulties in interpreting 2003). Because of difficulties in interpreting previous studies that themselves use stressprevious studies that themselves use stressful procedures, such as hospital admission, ful procedures, such as hospital admission, cannulation, blood removal and adminiscannulation, blood removal and administering drugs, we used a naturalistic measure tering drugs, we used a naturalistic measure of stress -the salivary cortisol response to of stress -the salivary cortisol response to awakening -to obtain an indication of awakening -to obtain an indication of the status of the HPA axis in CFS. the status of the HPA axis in CFS.
METHOD METHOD Subjects Subjects
Patients aged 18-65 years with CFS were Patients aged 18-65 years with CFS were recruited into the study from consecutive recruited into the study from consecutive referrals to the CFS clinic at King's College referrals to the CFS clinic at King's College Hospital, London. A total of 56 patients Hospital, London. A total of 56 patients agreed to participate. Patients had underagreed to participate. Patients had undergone thorough medical screening to exclude gone thorough medical screening to exclude a detectable organic cause for their fatigue, a detectable organic cause for their fatigue, including physical examination and releincluding physical examination and relevant investigation, with a minimum of vant investigation, with a minimum of urinalysis, full blood count, urea and urinalysis, full blood count, urea and electrolytes, thyroid function tests, liver electrolytes, thyroid function tests, liver function tests, 9 a.m. cortisol and erythrofunction tests, 9 a.m. cortisol and erythrocyte sedimentation rate. All patients cyte sedimentation rate. All patients initially were interviewed using a semiinitially were interviewed using a semistructured interview (Sharpe structured interview (Sharpe et al et al, 1997 (Sharpe et al et al, ) , 1997 for CFS by a psychiatrist: included subjects for CFS by a psychiatrist: included subjects had to fulfil both of the major international had to fulfil both of the major international consensus criteria for CFS (Sharpe consensus criteria for CFS (Sharpe et al et al, , 1991; Fukuda 1991; Fukuda et al et al, 1994) . Subjects then , 1994) . Subjects then were interviewed using the Schedules for were interviewed using the Schedules for Clinical Assessment in Neuropsychiatry Clinical Assessment in Neuropsychiatry (SCAN; World Health Organization, (SCAN; World Health Organization, 1994) adapted for DSM-IV (American Psy-1994) adapted for DSM-IV (American Psychiatric Association, 1994) -subjects who chiatric Association, 1994) -subjects who had an exclusionary psychiatric diagnosis had an exclusionary psychiatric diagnosis according to the clinical diagnostic criteria according to the clinical diagnostic criteria were therefore excluded at this point. Each were therefore excluded at this point. Each subject gave a detailed history including subject gave a detailed history including length of illness, the presence of any precilength of illness, the presence of any precipitating factors (such as viral infections) pitating factors (such as viral infections) and past psychiatric disorder. Patients and past psychiatric disorder. Patients who also fulfilled the criteria for who also fulfilled the criteria for fibromyalgia as defined by the American fibromyalgia as defined by the American College of Rheumatology were excluded College of Rheumatology were excluded (Wolfe (Wolfe et al et al, 1990) . These exclusions were , 1990). These exclusions were made in order to obtain as uniform and made in order to obtain as uniform and homogeneous a sample as possible, minihomogeneous a sample as possible, minimising comorbidity. mising comorbidity.
Thirty-five control subjects, recruited Thirty-five control subjects, recruited from staff, students and volunteers at our from staff, students and volunteers at our institutions, also took part in the salivary institutions, also took part in the salivary cortisol test. Present or past significant cortisol test. Present or past significant medical or psychiatric illness was excluded medical or psychiatric illness was excluded by a research nurse using a semi-structured by a research nurse using a semi-structured interview. Control subjects also were interinterview. Control subjects also were interviewed using the SCAN to exclude major viewed using the SCAN to exclude major psychiatric illness. psychiatric illness.
All control subjects and 46/56 patients All control subjects and 46/56 patients were free from psychotropic medication, were free from psychotropic medication, steroids or medication known to affect the steroids or medication known to affect the HPA axis for a minimum of 2 months prior HPA axis for a minimum of 2 months prior to endocrine testing. Ten patients were to endocrine testing. Ten patients were taking medication at the time of testing: taking medication at the time of testing: nine were taking antidepressants (of whom nine were taking antidepressants (of whom two were taking additional hypnotics and two were taking additional hypnotics and one was taking sodium valproate) and one one was taking sodium valproate) and one was taking pizotifen for migraine. All was taking pizotifen for migraine. All female subjects were tested during days 1-7 female subjects were tested during days 1-7 of their menstrual cycle. of their menstrual cycle.
The institutional ethics committee The institutional ethics committee approved all procedures. All patients and approved all procedures. All patients and controls gave written informed consent. controls gave written informed consent.
Questionnaires Questionnaires
Subjects filled out the following questionSubjects filled out the following questionnaires to assess illness characteristics: the naires to assess illness characteristics: the Chalder Fatigue Scale (Chalder Chalder Fatigue Scale (Chalder et al et al, , 1993 ) and a global fatigue rating scale 1993) and a global fatigue rating scale (Vercoulen (Vercoulen et al et al, 1997) for fatigue severity; , 1997) for fatigue severity; the Beck Depression Inventory (Beck the Beck Depression Inventory (Beck et al et al, , 1961) and General Health Questionnaire-1961) and General Health Questionnaire-12 (Goldberg, 1972) for symptoms of 12 (Goldberg, 1972) 
Salivary cortisol test Salivary cortisol test
Free cortisol is present in saliva, and saliFree cortisol is present in saliva, and salivary cortisol assays have been shown to vary cortisol assays have been shown to be an accurate indicator of total plasma be an accurate indicator of total plasma cortisol (Tunn cortisol (Tunn et al et al, 1992) and plasma free , 1992) and plasma free cortisol (Kirschbaum & Hellhammer, cortisol (Kirschbaum & Hellhammer, 1994) . Furthermore, it has been well deli-1994). Furthermore, it has been well delineated that cortisol levels rapidly increase neated that cortisol levels rapidly increase after awakening by around 50-60% after awakening by around 50-60% (Linkowski (Linkowski et al et al, 1993; Van Cauter , 1993; Van Cauter et al et al, , 1994; Wust 1994; Wust et al et al, 2000 Wust et al et al, , 2000b and remain ) and remain elevated for at least 60 min (Schmidtelevated for at least 60 min (SchmidtReinwald Reinwald et al et al, 1999) . Awakening thus acts , 1999). Awakening thus acts as a mild stressor and the increase in cortias a mild stressor and the increase in cortisol gives an indication of the responsivity of sol gives an indication of the responsivity of the HPA axis; furthermore, it has the the HPA axis; furthermore, it has the advantage that salivary testing can be advantage that salivary testing can be completed in a naturalistic setting, thus completed in a naturalistic setting, thus eliminating the confounding stress and eliminating the confounding stress and anxiety associated with both intravenous anxiety associated with both intravenous cannulation and hospital attendance. cannulation and hospital attendance. Recent work compared the results from this Recent work compared the results from this test with the more traditional HPA axis test with the more traditional HPA axis tests, such as the corticotrophin-releasing tests, such as the corticotrophin-releasing hormone (CRH) hormone (CRH) test, adrenocorticotrophic test, adrenocorticotrophic hormone (ACTH) hormone (ACTH) test and social stress test and social stress tests, and concluded that it is a useful and tests, and concluded that it is a useful and reliable index of the adrenocortical activity, reliable index of the adrenocortical activity, perhaps most closely correlated with perhaps most closely correlated with the ACTH test of adrenal reserve the ACTH test of adrenal reserve (Schmidt-Reinwald (Schmidt-Reinwald et al et al, 1999; Wust , 1999; Wust et et al al, 2000 Wust et et al al, , 2000b . Furthermore, results from the ). Furthermore, results from the study of over 500 subjects suggest that the study of over 500 subjects suggest that the response is not significantly affected by response is not significantly affected by age, sleep duration, time of awakening, age, sleep duration, time of awakening, use of an alarm clock, smoking or use of use of an alarm clock, smoking or use of an oral contraceptive, and is stable over an oral contraceptive, and is stable over time (Wust time (Wust et al et al, 2000 (Wust et al et al, , 2000b . ). All tests were undertaken at home on a All tests were undertaken at home on a normal weekday: subjects who were worknormal weekday: subjects who were working were instructed to choose any workday ing were instructed to choose any workday except Monday. Subjects were free to wake except Monday. Subjects were free to wake up according to their normal schedule up according to their normal schedule because the awakening cortisol profile does because the awakening cortisol profile does not appear to be altered by differences in not appear to be altered by differences in time of awakening (Pruessner time of awakening (Pruessner et al et al, 1997) . , 1997). Subjects were asked to take the first sample Subjects were asked to take the first sample while still in bed and then not to have while still in bed and then not to have breakfast or brush their teeth during the breakfast or brush their teeth during the first hour after awakening in order to avoid first hour after awakening in order to avoid falsely high cortisol values due to plasma falsely high cortisol values due to plasma exudates from minor bleeding in the oral exudates from minor bleeding in the oral cavity (or from meal-stimulated rises in cavity (or from meal-stimulated rises in cortisol). For the 10 min prior to each cortisol). For the 10 min prior to each sample, we asked subjects to remain sitting sample, we asked subjects to remain sitting and not to drink anything, smoke or chew and not to drink anything, smoke or chew gum. Saliva was collected directly upon gum. Saliva was collected directly upon waking and then 10, 20, 30 and 60 min waking and then 10, 20, 30 and 60 min after waking. During collection, subjects after waking. During collection, subjects were instructed not to touch the samples were instructed not to touch the samples with their hands. At each time point, with their hands. At each time point, subjects were asked to write down 'any subjects were asked to write down 'any difficult or tense conversations or other difficult or tense conversations or other ''hassles'' that you have experienced in the ''hassles'' that you have experienced in the last hour'. Samples were kept in the refriglast hour'. Samples were kept in the refrigerator overnight and sent back in the post erator overnight and sent back in the post in the morning. On arrival at the laboratory in the morning. On arrival at the laboratory they were frozen at they were frozen at 7 720 208 8C. After thawing, C. After thawing, saliva samples were centrifuged at 3000 rev/ saliva samples were centrifuged at 3000 rev/ min for 5 min, which resulted in a clear min for 5 min, which resulted in a clear supernatant of low viscosity. A 50 supernatant of low viscosity. A 50 m ml l aliquot of saliva was used for duplicate aliquot of saliva was used for duplicate analysis. Salivary cortisol was measured analysis. Salivary cortisol was measured using a time-resolved fluoroimmunoassay using a time-resolved fluoroimmunoassay as described elsewhere (Pariante as described elsewhere (Pariante et al et al, , 2002) , except that the rabbit cortisol anti-2002), except that the rabbit cortisol antibody (product no. 2330-5105, batch no. body (product no. 2330-5105, batch no. 21051565; Biogenesis, Poole, Dorset, UK) 21051565; Biogenesis, Poole, Dorset, UK) and the europium-labelled cortisol were and the europium-labelled cortisol were diluted 1:4500 and 1:65, respectively, in diluted 1:4500 and 1:65, respectively, in assay buffer before use. All samples of one assay buffer before use. All samples of one subject were analysed in the same run. subject were analysed in the same run.
Analysis Analysis
Data were checked to confirm normal Data were checked to confirm normal distribution and parametric statistics were distribution and parametric statistics were used. The primary outcome variable was used. The primary outcome variable was the total cortisol response to awakening, the total cortisol response to awakening, measured using the integrated area under measured using the integrated area under the curve (AUC). This was calculated by the curve (AUC). This was calculated by first subtracting the 0-min awakening value first subtracting the 0-min awakening value from the 10-, 20-, 30-and 60-min values, to from the 10-, 20-, 30-and 60-min values, to obtain baseline-corrected values, and then obtain baseline-corrected values, and then using the trapezoidal method. The AUC using the trapezoidal method. The AUC was compared between groups using an inwas compared between groups using an independent dependent t t-test. Secondary analysis on the -test. Secondary analysis on the main group difference only was undertaken main group difference only was undertaken by carrying out by carrying out post hoc t post hoc t-tests at each -tests at each baseline-corrected time point. Exploratory baseline-corrected time point. Exploratory analysis was undertaken to see whether analysis was undertaken to see whether clinical variables were related to the AUC clinical variables were related to the AUC response within the patient group and to response within the patient group and to define further the dynamics of the salivary define further the dynamics of the salivary cortisol response in the group as a whole. cortisol response in the group as a whole. Means and standard deviations are given. Means and standard deviations are given.
RESULTS RESULTS
Comparison of patients and Comparison of patients and controls controls
Patients and controls were well balanced Patients and controls were well balanced with regard to age, gender, weight and with regard to age, gender, weight and body mass index. Details of subjects and body mass index. Details of subjects and controls are shown in Table 1 . The mean controls are shown in Table 1 . The mean length of illness was 56 months at the time length of illness was 56 months at the time of testing and the mean SF-36 physical of testing and the mean SF-36 physical functioning sub-scale score was 39.4 functioning sub-scale score was 39.4 (s.d. Raw data at each time point are shown Raw data at each time point are shown in Table 2 . The cortisol level in the first in Table 2 . The cortisol level in the first sample after awakening was similar in both sample after awakening was similar in both 13 7 13 7 
DISCUSSION DISCUSSION
In this study we have demonstrated an
In this study we have demonstrated an impaired cortisol response to the naturalistic impaired cortisol response to the naturalistic stressor of awakening in a large sample of stressor of awakening in a large sample of carefully characterised patients with CFS. carefully characterised patients with CFS. More specifically, similar percentages of More specifically, similar percentages of patients and controls showed a significant patients and controls showed a significant rise to awakening, suggesting that this is a rise to awakening, suggesting that this is a valid challenge paradigm; however, the valid challenge paradigm; however, the mean response in patients was significantly mean response in patients was significantly less than that in controls. less than that in controls.
Comparison with prior studies Comparison with prior studies
Problems with previous studies have inProblems with previous studies have included those related to the patient samples cluded those related to the patient samples studied. To address some of the problems studied. To address some of the problems related to this issue, in this study we chose related to this issue, in this study we chose to include only subjects meeting the clinical to include only subjects meeting the clinical diagnostic criteria for CFS. We used a gold diagnostic criteria for CFS. We used a gold 13 8 13 8 standard assessment instrument for depresstandard assessment instrument for depression -SCAN -in order to assess clearly sion -SCAN -in order to assess clearly whether comorbid depressive illness could whether comorbid depressive illness could influence the results. We chose a group influence the results. We chose a group largely free from medication that might largely free from medication that might influence the HPA axis. influence the HPA axis. We are aware of only one prior study We are aware of only one prior study (Gaab (Gaab et al et al, 2002 (Gaab et al et al, , 2002b in which the salivary ) in which the salivary cortisol response to awakening was cortisol response to awakening was measured, although on a much smaller measured, although on a much smaller group of 21 subjects with CFS. That partigroup of 21 subjects with CFS. That particular study failed to find any significant cular study failed to find any significant difference in morning response in patients difference in morning response in patients and controls. However, the authors did find and controls. However, the authors did find a supersuppression to dexamethasone, a supersuppression to dexamethasone, consistent with HPA axis underactivity, consistent with HPA axis underactivity, perhaps related to enhanced glucocorticoid perhaps related to enhanced glucocorticoid receptor sensitivity. receptor sensitivity.
Nevertheless, our finding of impaired Nevertheless, our finding of impaired cortisol response is in keeping with the cortisol response is in keeping with the findings from several studies using CRH findings from several studies using CRH and synthetic ACTH, which have also and synthetic ACTH, which have also found impaired cortisol response (Cleare, found impaired cortisol response (Cleare, 2003) . It is also in keeping with the findings 2003). It is also in keeping with the findings from our group of reduced total 24-h from our group of reduced total 24-h urinary free cortisol output (Cleare urinary free cortisol output (Cleare et al et al, , 2001 
Comorbid depression Comorbid depression
We found that the presence or absence of We found that the presence or absence of depression did not materially alter the finddepression did not materially alter the finding. This is similar to the finding in our ing. This is similar to the finding in our large study of 24-h urinary free cortisol large study of 24-h urinary free cortisol (Cleare (Cleare et al et al, 2001) , where output was , 2001), where output was reduced regardless of present or past psyreduced regardless of present or past psychiatric illness. Because the available chiatric illness. Because the available evidence suggests that the atypical subtype evidence suggests that the atypical subtype of depression may be associated also with of depression may be associated also with lowered HPA axis function, and has lowered HPA axis function, and has fatigue (or 'leaden paralysis') as a promifatigue (or 'leaden paralysis') as a prominent symptom, the emerging evidence is nent symptom, the emerging evidence is that the depression seen in CFS is more in that the depression seen in CFS is more in keeping both biologically and phenomenokeeping both biologically and phenomenologically with that subtype. We are not logically with that subtype. We are not aware of published research investigating aware of published research investigating the cortisol response to awakening in the cortisol response to awakening in depression itself. depression itself.
Chronic stress Chronic stress
The previous work that has been underThe previous work that has been undertaken using this test has concluded that taken using this test has concluded that chronic social stress (Wust chronic social stress (Wust et al et al, 2000 , 2000a a) ) or a high level of perceived stress (Pruessner or a high level of perceived stress (Pruessner et al et al, 1999) leads to an enhanced awaken-, 1999) leads to an enhanced awakening response. We did not assess these variing response. We did not assess these variables specifically in this study but our ables specifically in this study but our results suggest that patients with CFS do results suggest that patients with CFS do not share the characteristics of otherwise not share the characteristics of otherwise healthy individuals under situations of healthy individuals under situations of chronic stress. Following on from this, a chronic stress. Following on from this, a further hypothesis might be that subjects further hypothesis might be that subjects with CFS are generally less responsive to with CFS are generally less responsive to acute naturalistic stressors. However, acute naturalistic stressors. However, although Gaab although Gaab et al et al did find a reduced did find a reduced ACTH response to social stress (public ACTH response to social stress (public speaking) and exercise stress, the salivary speaking) and exercise stress, the salivary cortisol responses were the same but in a cortisol responses were the same but in a relatively small sample of 21 (Gaab relatively small sample of 21 (Gaab et al et al, , 2002 (Gaab et al et al, , 2002a . ).
Effect of other confounding factors Effect of other confounding factors
Ten of our 56 subjects with CFS were takTen of our 56 subjects with CFS were taking prescribed medication liable to affect ing prescribed medication liable to affect the HPA axis. Although we did not find a the HPA axis. Although we did not find a significant difference, the values were lower significant difference, the values were lower and this might have represented a type II and this might have represented a type II error. Indeed, we have argued previously error. Indeed, we have argued previously that medication is likely to be one of the that medication is likely to be one of the many factors contributing to HPA axis dysmany factors contributing to HPA axis dysfunction in CFS. It seems most likely that function in CFS. It seems most likely that the observed HPA deficits in CFS are of the observed HPA deficits in CFS are of multi-factorial origin rather than representmulti-factorial origin rather than representing a single change to the HPA axis. ing a single change to the HPA axis. Important factors that may be contributing Important factors that may be contributing to HPA axis dysfunction include: disturbed to HPA axis dysfunction include: disturbed sleep, reduced physical activity, psychiatric sleep, reduced physical activity, psychiatric comorbidity; effects of early life expericomorbidity; effects of early life experiences on the HPA such as childhood abuse; ences on the HPA such as childhood abuse; medication effects; presence and response medication effects; presence and response to ongoing psychosocial stressors; and the to ongoing psychosocial stressors; and the different influences of these factors during different influences of these factors during different illness phases (i.e. acute, sub-acute different illness phases (i.e. acute, sub-acute and chronic fatigue of varying durations). and chronic fatigue of varying durations). Heterogeneity of these factors would Heterogeneity of these factors would appear likely to underlie the inconsistent appear likely to underlie the inconsistent and divergent findings seen to date. Despite and divergent findings seen to date. Despite this, there remain suggestions that HPA this, there remain suggestions that HPA dysfunction, and in particular low circulatdysfunction, and in particular low circulating cortisol levels, may be one factor contriing cortisol levels, may be one factor contributing to fatigue chronicity in CFS that is buting to fatigue chronicity in CFS that is potentially reversible (Cleare potentially reversible (Cleare et al et al, 1999) . , 1999).
Characteristics of salivary cortisol Characteristics of salivary cortisol test test
Finally, we provide further evidence in this Finally, we provide further evidence in this paper regarding the characteristics of this paper regarding the characteristics of this novel test. First, in our control group we novel test. First, in our control group we found a consistent rise of approximately found a consistent rise of approximately 40% over baseline, similar to previous 40% over baseline, similar to previous reports suggesting a rise of around 50% reports suggesting a rise of around 50% (Wust (Wust et al et al, 2000 , 2000b b) . Similarly, our finding ). Similarly, our finding that around 71% of controls showed a that around 71% of controls showed a 'response' to awakening (2.5 nmol/l or 'response' to awakening (2.5 nmol/l or more over baseline, as previously defined) more over baseline, as previously defined) tallies with the figure of 75% reported pretallies with the figure of 75% reported previously (Wust viously (Wust et al et al, 2000 (Wust et al et al, , 2000b . We also found ). We also found that smoking, sleep quality and awakening that smoking, sleep quality and awakening time do not have a significant effect on time do not have a significant effect on the response, in accordance with the prethe response, in accordance with the previous literature (Wust vious literature (Wust et al et al, 2000 (Wust et al et al, , 2000b . A small ). A small gender effect has also been reported in the gender effect has also been reported in the direction of higher response in females direction of higher response in females (Wust (Wust et al et al, 2000 (Wust et al et al, , 2000b , which is consistent ), which is consistent with our findings here. It is of note that with our findings here. It is of note that we have sampled somewhat more frewe have sampled somewhat more frequently over the first 30 min of awakening quently over the first 30 min of awakening than prior studies. We found that around than prior studies. We found that around half of the tests showed the peak response half of the tests showed the peak response before 30 min, suggesting that future before 30 min, suggesting that future studies should include sampling times studies should include sampling times before 30 min after awakening. before 30 min after awakening.
Limitations Limitations
One of the limitations of our study relates One of the limitations of our study relates to the chosen population, which was to the chosen population, which was recruited from those referred to a tertiary recruited from those referred to a tertiary care centre. We cannot directly extrapolate care centre. We cannot directly extrapolate these results to those with chronic fatigue these results to those with chronic fatigue seen in the community, where the HPA axis seen in the community, where the HPA axis may be less relevant or less affected. For may be less relevant or less affected. For example, recent studies of the early stages example, recent studies of the early stages of development of chronic fatigue in highof development of chronic fatigue in highrisk samples, such as in the 6 months after risk samples, such as in the 6 months after Epstein-Barr infection (Candy Epstein-Barr infection (Candy et al et al, 2003) , 2003) or major surgery (Rubin, 2003) , suggest or major surgery (Rubin, 2003) , suggest no link between chronic fatigue and the no link between chronic fatigue and the HPA axis. This has led to the suggestion HPA axis. This has led to the suggestion by some that HPA axis changes occur late by some that HPA axis changes occur late in the course of the illness history in CFS, in the course of the illness history in CFS, and may be consequent to the illness rather and may be consequent to the illness rather than causal (Cleare, 2003) . than causal (Cleare, 2003) .
Another factor to be considered is Another factor to be considered is sample size. Although overall we recruited sample size. Although overall we recruited a relatively large sample of patients coma relatively large sample of patients compared with previous work in the field, the pared with previous work in the field, the exploratory analyses looking at the effects exploratory analyses looking at the effects of depression and medication use, among of depression and medication use, among other factors, involve sub-groups of the other factors, involve sub-groups of the patient sample. Therefore, there is a posspatient sample. Therefore, there is a possibility of type II errors in these analyses. ibility of type II errors in these analyses.
In conclusion, this study provides In conclusion, this study provides further evidence for HPA axis dysfunction further evidence for HPA axis dysfunction in CFS. It advances previous work by in CFS. It advances previous work by undertaking testing in a more naturalistic undertaking testing in a more naturalistic setting and by using a novel, non-invasive setting and by using a novel, non-invasive test of the cortisol response to the stress of test of the cortisol response to the stress of awakening in a larger sample size than awakening in a larger sample size than most prior work in the area. most prior work in the area. The sample size was too small to tease out many of the possible factors contributing to the impaired HPA axis response in CFS. contributing to the impaired HPA axis response in CFS.
& & Because this is a cross-sectional study, we cannot say whether the observed HPA Because this is a cross-sectional study, we cannot say whether the observed HPA axis changes are a primary aetiological feature of CFS or occur as a consequence of axis changes are a primary aetiological feature of CFS or occur as a consequence of CFS and its numerous effects on sufferers. CFS and its numerous effects on sufferers. 
